product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Mouse anti Human RNA Pol II CTD (pSer2/pSer5)
catalog :
MCA6374
quantity :
0.1 mg
price :
580 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
1A12G10
reactivity :
human
application :
western blot, immunocytochemistry
more info or order :
image
image 1 :

Western blot analysis of HeLa cell nuclear extract (30 µg) probed with POL II CTD (pSer2/pSer5) antibody (MCA6374) at a 1 ug/ml dilution.
product information
Entity Type :
Monoclonal Antibody
Entity Category :
Antibodies
ProductCode :
MCA6374
Description :
Mouse anti Human RNA Pol II CTD (pSer2/pSer5)
Specificity :
RNA Pol II CTD (pSer2/pSer5)
TargetSpecies :
Human
Host :
Mouse
Format :
Purified
Isotypes :
IgG1
Applications :
WB,IF,Ch
ApplicationTypes :
Western Blotting,Immunofluorescence,Chromatin Immunoprecipitation
Clone :
1A12G10
Quantity :
0.1 mg
Quantity Value :
0.1
Quantity Type :
mg
GO Accessions :
GO:0000398,GO:0003677,GO:0003899,GO:0003968,GO:0046872,GO:0005665,GO:0006283,GO:0006355,GO:0006367,GO:0006368,GO:0006370,GO:0016032,GO:0031625,GO:0050434
GOTerms :
nuclear mRNA splicing, via spliceosome,DNA binding,DNA-directed RNA polymerase activity,RNA-directed RNA polymerase activity,metal ion binding,DNA-directed RNA polymerase II, core complex,transcription-coupled nucleotide-excision repair,regulation of transcription, DNA-dependent,transcription initiation from RNA polymerase II promoter,transcription elongation from RNA polymerase II promoter,mRNA capping,viral reproduction,ubiquitin protein ligase binding,positive regulation of viral transcription
Uniprot Accessions :
P24928
Gene :
POLR2A
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=5430
Published Synonyms :
RPB1
Entity Formats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 1.0 mg/ml
Product Form :
Purified IgG - liquid
PriceGBP :
415
PriceEUR :
580
PriceUSD :
580 USD
PriceCHF :
631
PriceSEK :
6322
PriceNOK :
6353
PriceDKK :
4324
more info or order :
company information

Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
related products
browse more products
questions and comments